ClostraBio Sales Battle Card: Board Hire & Safety Data

Scott Ravech joins ClostraBio board. CLB101™ safety data published. Pitch compliance and speed to market.

Published on


Do not index
Do not index

🚀 Battle Card: ClostraBio, Inc.

Quick trigger:
 
👤 Decision Maker in the News
 
💡 Why It Matters
  • Brings seasoned probiotic leadership and validated safety data, accelerating go-to-market confidence. Use this ClostraBio, Inc. sales trigger to lead with credibility. → Source
 
🎯 Core Pain Point
  • Regulatory & safety validation hurdles for novel microbiome platforms
  • Speed to market with practitioner-focused supplement launches
 
💰 What to Pitch
  • Primary: Safety & Compliance Solutions → Mitigate risk, fast-track GRAS validation
  • Expansion: GTM Enablement Tools → Streamline practitioner channel rollout
 
🗺️ Quick Context
  • HQ: Chicago, IL
  • Employees: ≈ 60
  • Rev: ≈ $3 M
 

🤼 Competitive Intel

*Which other vendors you’ll probably face to win **ClostraBio, Inc.*’s business.
 

Sales Solutions

  • SalesforceCRM / Sales Automation
    • Unique edge: End-to-end pipeline visibility
    • Evaluated by VP Sales for scalability
  • HubSpotCRM / Inbound Marketing
    • Unique edge: Integrated marketing & sales hub
    • Evaluated by Dir. Marketing for ease of use
  • OutreachSales Engagement
    • Unique edge: AI-driven sequencing automation
    • Evaluated by Sales Ops for productivity
 

Marketing Solutions

  • MarketoMarketing Automation
    • Unique edge: Deep lead management workflows
    • Evaluated by CMO for lead nurturing
  • PardotB2B Marketing Automation
    • Unique edge: Native Salesforce integration
    • Evaluated by Dir. Demand Gen for ABM
  • MailchimpEmail Marketing
    • Unique edge: User-friendly campaign builder
    • Evaluated by Marketing teams for quick deployment
 

Ops & Supply Chain Solutions

  • SAPERP / SCM
    • Unique edge: Enterprise-grade global support
    • Evaluated by COO & VP Ops for end-to-end traceability
  • OracleERP / SCM
    • Unique edge: Unified finance & supply chain suite
    • Evaluated by CFO for cost optimization
  • KinaxisSupply Chain Planning
    • Unique edge: Real-time scenario simulation
    • Evaluated by Supply Chain Directors for agility
 

✅ Do-Now Checklist

Connect with Scott Ravech on LinkedIn (link above)
Email sequence referencing this ClostraBio, Inc. sales trigger & compliance pitch
Schedule follow-ups in CRM (Day 3 & Day 10)
 

Next Step

Get daily triggers like this ClostraBio, Inc. sales trigger—no fluff, all pipeline. Subscribe to NewsletterForLeads
 

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑❑
PROOF_METRIC  = ❑❑
CTA_STYLE     = ❑❑
TONE          = ❑❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Scott
COMPANY     = ClostraBio, Inc.
DEPT        = Board of Directors
SIZE        = ≈ TBD
BOTTLENECK  = Regulatory & safety validation hurdles
EVENT       = ≈ TBD
DETAIL      = ≈ TBD
PAIN        = ≈ TBD
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250916252766&div=41152219
SIM_CO      = Deerland Probiotics & Enzymes
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 60
REV_EST     = ≈ $3 M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ TBD-person Board of Directors

Scott—noticed your Board of Directors team is ≈ TBD.
That’s when Regulatory & safety validation hurdles slows growth.
We helped Deerland Probiotics & Enzymes fix this with ≈ TBD.
Result: ≈ TBD.
Want the 2-min recap?

PS—next bottleneck hits ≈ ≈ TBD.

DM ≤45 words, TONE:
Saw your post about ≈ TBD — ≈ TBD.
≈ TBD. ≈ TBD.
Send case study?

Join other 3200+ marketers now!

Ready to take the next big step for your business?

Subscribe